"We deeply respect Neuron Endowment Fund and its work. The way they support young talented scientists. It is my pleasure to support Czech research."
Czech biochemist, specialist in virology.
Tomáš Cihlář is a Czech biochemist known for his role in the development of remdesivir. A specialist in virology, Cihlář holds the positions of Senior Director, Biology, and Vice-President at American pharmaceutical company Gilead Sciences.
As a student, Cihlář assisted fellow biochemist Antonín Holý in developing Viread, the primary drug used to fight HIV infection.